What makes MyOme's rare disease offering unique?
Comprehensive genomic analysis, flexible testing options, and patient-centric approach.
- Comprehensive Genomic Analysis: Built on a whole genome backbone, the rare disease tests shorten the diagnostic odyssey by eliminating the need for multiple, sequential tests
- Flexible Testing Options: Available to order as genome and exome analysis (proband-only or with duo/trio analysis including up to two first-degree relatives to enhance variant interpretation) as well as copy number analysis.
- Patient-Centric Approach: Compassionate clinical support, transparent billing, and access to genetic counseling.